Mereo BioPharma (MREO) Amortizatization of Intangibles (2023 - 2026)
Mereo BioPharma (MREO) reported Amortizatization of Intangibles of $127000.0 for Q1 2026, up 0.79% year-over-year from $126000.0 in Q1 2025, and down 3.79% quarter-over-quarter from $132000.0 in Q4 2025.
Mereo BioPharma (MREO) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 4 years of Amortizatization of Intangibles data on file, last reported at $127000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $127000.0, up 0.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $528000.0 (up 15.79% YoY), and the FY2025 annual result was $527000.0, up 20.32% from the prior year.
- Amortizatization of Intangibles declined to $127000.0 in Q1 2026 per MREO's latest filing, from $132000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $215000.0 in Q4 2023 and troughed at $50000.0 in Q2 2023.
- A 4-year average of $122076.9 and a median of $112000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 116.0% in 2024 and fell as far as 48.84% in 2024.
- A 4-year view of Amortizatization of Intangibles shows it stood at $215000.0 in 2023, then plunged by 48.84% to $110000.0 in 2024, then increased by 20.0% to $132000.0 in 2025, then retreated by 3.79% to $127000.0 in 2026.
- Business Quant data shows MREO's Amortizatization of Intangibles at $127000.0 in Q1 2026, $132000.0 in Q4 2025, and $171000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | 127,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 127,000.00 |
| Mar 31, 2026 | 127,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Sep 30, 2025 | 171,000.00 |
| Sep 30, 2025 | 171,000.00 |
| Jun 30, 2025 | 98,000.00 |
| Jun 30, 2025 | 98,000.00 |
| Mar 31, 2025 | 126,000.00 |
| Mar 31, 2025 | 126,000.00 |
| Dec 31, 2024 | 110,000.00 |
| Dec 31, 2024 | 110,000.00 |
| Sep 30, 2024 | 112,000.00 |
| Sep 30, 2024 | 112,000.00 |
| Jun 30, 2024 | 108,000.00 |
| Jun 30, 2024 | 108,000.00 |
| Mar 31, 2024 | 108,000.00 |
| Mar 31, 2024 | 108,000.00 |
| Dec 31, 2023 | 215,000.00 |
| Dec 31, 2023 | 215,000.00 |